CAS 273404-37-8
:N-(4-Amino-3-clorobenzoyl)-3-metil-L-valil-N-[(2R,3S)-2-etoxitetrahidro-5-oxo-3-furanil]-L-prolinamida
Descripción:
Belnacasan (273404-37-8) is a prodrug of VRT-043198, a potent (Ki = 0.8 nM ICE/caspase-1; <0.6nM caspase-4) and selective inhibitor of interleukin-converting enzyme/caspase-1 subfamily caspases.1 VRT-043198 ICE/caspase-1 IC50 = 0.67 μM PBMCs, 1.0 μM whole blood.? It inhibited the release of IL-1b and IL-18 from human monocytes in vitro and their production in vivo in models of inflammation. Belnacasan inhibited the activation and expression of the NLRP3 Inflammasome leading to moderation of depressive-like behaviors induced by chronic mild stress2 and prevention of glial pyroptosis in multiple sclerosis models3. It inhibited pyroptosis in vascular smooth muscle cells during atherogenesis suggesting a possible therapeutic effect in treating atherosclerotic disease.4 Belnacasan reduced acute seizures and drug resistant chronic epileptic activity in mice5 and provided neuroprotection in two rat models of temporal lobe epilepsy6.? It also displays protective effects in models of stroke7and Alzheimer’s disease8.
Fórmula:C24H33ClN4O6
InChI:InChI=1S/C24H33ClN4O6/c1-5-34-23-16(12-18(30)35-23)27-21(32)17-7-6-10-29(17)22(33)19(24(2,3)4)28-20(31)13-8-9-15(26)14(25)11-13/h8-9,11,16-17,19,23H,5-7,10,12,26H2,1-4H3,(H,27,32)(H,28,31)/t16-,17-,19+,23+/m0/s1
Clave InChI:InChIKey=SJDDOCKBXFJEJB-MOKWFATOSA-N
SMILES:C([C@@H](NC(=O)C1=CC(Cl)=C(N)C=C1)C(C)(C)C)(=O)N2[C@H](C(N[C@@H]3[C@H](OCC)OC(=O)C3)=O)CCC2
Sinónimos:- <span class="text-smallcaps">L</smallcap>-Prolinamide, N-(4-amino-3-chlorobenzoyl)-3-methyl-<smallcap>L</span>-valyl-N-[(2R,3S)-2-ethoxytetrahydro-5-oxo-3-furanyl]-
- Belnacasan
- N-(4-Amino-3-chlorobenzoyl)-3-methyl-<span class="text-smallcaps">L</smallcap>-valyl-N-[(2R,3S)-2-ethoxytetrahydro-5-oxo-3-furanyl]-<smallcap>L</span>-prolinamide
- Vx 765
- Vx765
- VX 786
- N-(4-Amino-3-chlorobenzoyl)-3-methyl-L-valyl-N-[(2R,3S)-2-ethoxytetrahydro-5-oxo-3-furanyl]-L-prolinamide
- L-Prolinamide, N-(4-amino-3-chlorobenzoyl)-3-methyl-L-valyl-N-[(2R,3S)-2-ethoxytetrahydro-5-oxo-3-furanyl]-
- (S)-1-((S)-2-(4-amino-3-chlorobenzamido)-3,3-dimethylbutanoyl)-N-((2R,3S)-2-ethoxy-5-oxotetrahydrofuran-3-yl)pyrrolidine-2-carboxamide USP/EP/BP
- BELNACASAN;VX-765;VX 765
- Caspase-1-4 Inhibitor VX-765
- (S)-1-((S)-2-(4-amino-3-chlorobenzamido)-3,3-dimethylbutanoyl)-N-((2R,3S)-2-ethoxy-5-oxotetrahydrofuran-3-yl)pyrrolidine-2-carboxamide
- Belnacasan (VX765)
- VX-765(Belnacasan)
- CS-387
- VX 765; VX-765; VX765. BELNACASAN
- (S)-1-((S)-2-(4-Amino-3-chlorobenzamido)-3,3-dimethylbutanoyl)-N-((2R,3S)-2-ethoxy-5-oxotetrah
- (2S)-1-[(2S)-2-[(4-amino-3-chlorophenyl)formamido]-3,3-dimethylbutanoyl]-N-[(2R,3S)-2-ethoxy-5-oxooxolan-3-yl]pyrrolidine-2-carboxamide
- VX-765,VX 765
- Ver más sinónimos
Ordenar por
Pureza (%)
0
100
|
0
|
50
|
90
|
95
|
100
Se han encontrado 7 productos.
VX-765
CAS:Fórmula:C24H33ClN4O6Pureza:>95.0%(HPLC)Forma y color:White to Light yellow powder to crystalPeso molecular:509.00VX-765
CAS:(S)-1-((S)-2-(4-Amino-3-chlorobenzamido)-3,3-dimethylbutanoyl)-N-((2R,3S)-2-ethoxy-5-oxotetrahydrofuran-3-yl)pyrrolidine-2-carboxamideFórmula:C24H33ClN4O6Pureza:99%Peso molecular:509.0(2S)-1-[(2S)-2-[(4-amino-3-chlorophenyl)formamido]-3,3-dimethylbutanoyl]-N-[(2R,3S)-2-ethoxy-5-oxooxolan-3-yl]pyrrolidine-2-carboxamide
CAS:Fórmula:C24H33ClN4O6Pureza:98%Forma y color:SolidPeso molecular:508.9950Belnacasan
CAS:Belnacasan (VX-765) is an orally active IL-converting enzyme/caspase-1 inhibitor.Fórmula:C24H33ClN4O6Pureza:96.53% - 99.5%Forma y color:SolidPeso molecular:508.99Ref: TM-T6090
2mg34,00€5mg52,00€1mL*10mM (DMSO)52,00€10mg81,00€25mg161,00€50mg222,00€100mg396,00€200mg585,00€VX-765
CAS:Producto controladoApplications VX-765 shows anti-convulsant activity by inhibiting interlukin-1β biosynthesis.
References Maroso, M. et al.: Neurother., 8, 304 (2011); Galatsis, P. et al.: Bioorg. Med. Chem. Lett., 20, 5184 (2010);Fórmula:C24H33ClN4O6Forma y color:NeatPeso molecular:509.00VX 765
CAS:A prodrug of VRT 043198 that inhibits IL-converting enzyme (ICE)/caspase-1. Inhibits LPS-induced secretion of cytokines. It has therapeutic potential in autoinflammatory diseases. VX 765 is cardioprotective in addition to the P2Y12 receptor inhibitor congrelor, resulting in reduced myocardial infarction.
Fórmula:C24H33ClN4O6Pureza:Min. 95%Forma y color:White PowderPeso molecular:508.99 g/mol






